Effectiveness of different tirofiban administration times in patients with no-reflow myocardial infarction during percutaneous coronary intervention
Compared with the direct application of tirofiban, tirofiban given when TIMI Grade≥ 1 for patients with no-reflow MI during PCI can more effectively regulate the blood flow status of target vessels, reduce myocardial injury, and reduce the risk of MACE.
Authors
- Huiping Yu
- C. Mei
Institutions
- Wuhan University of Science and Technology (CN)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2024-09-09
- DOI
- https://doi.org/10.12669/pjms.40.9.10101
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00